Enterprise Account Executive
About the job
- Experience in HR technology, compensation technology, or pay equity, whether as a practitioner, consultant or advisor, or account executive selling into the space.
- Demonstrated quota-carrying experience in enterprise software-as-a-service sales, ideally in a high-value, low-transaction-volume environment.
- Experience with deliverable-based selling, including building presentations, business cases, and value assessments that shape value-based sales cycles.
- Proven ability to navigate enterprise buying committees and build multi-threaded relationships across prospect organizations.
- Strong presentation and listening skills, with the ability to engage multiple senior stakeholders and C-level contacts at once.
- A track record of closing deals through long, complex enterprise sales cycles.
- Experience with Salesforce and HubSpot or similar customer relationship management tools.
- Build and manage a pipeline of enterprise named accounts, partnering with Sales Development and Marketing to generate qualified leads.
- Develop deep expertise in the company's compensation, pay equity and transparency, and performance management solutions.
- Own complex, multi-stakeholder sales cycles end-to-end, from qualification to close.
- Create business cases and value assessments that support enterprise buying decisions.
- Partner with deal teams to shape opportunity plans and sales deliverables.
- Represent the company at industry events, seminars, and in the press.
About the company
Beqom provides Total Compensation Management software for large enterprises as a SaaS platform that handles salaries, bonuses, incentives, benefits, and related processes. It works via modules for sales incentive management, performance management, quota management, and territory management in the cloud, with customization to fit each organization’s rules. It differentiates itself through flexible, enterprise-grade capabilities that adapt to unique compensation scenarios across industries, serving clients like Orange, Barclays, Microsoft, and Deutsche Post DHL Group. The goal is to improve efficiency in compensation planning and review, boost employee satisfaction, and drive better business results by simplifying and optimizing how pay is planned and awarded.
Company Size
201-500
Company Stage
Growth Equity (Venture Capital)
Total Funding
$359.6M
Headquarters
Nyon, Switzerland
Founded
2009
Get referred to Beqom
See people who can refer or advise you
Simplify's Take
What believers are saying
- Sumeru's $300 million investment funds product expansion and global sales capacity.
- Lars Pedersen became CEO on January 8, 2025, sharpening enterprise execution.
- Novo Insights named beqom top-tier for enterprise pay equity and pay transparency in 2026.
What critics are saying
- G2 lists SAP SuccessFactors, UKG Pro, and Payscale Ascent as top alternatives.
- Enterprise compensation deployments replace spreadsheets slowly, delaying beqom revenue recognition and expansions.
- Workday or SAP bundling compensation and pay equity can relegate beqom to niche status.
What makes Beqom unique
- beqom unifies salaries, bonuses, incentives, and pay equity for global enterprises.
- Its 2026 report centers AI-driven compensation decisions and pay transparency workflows.
- PayAnalytics acquisition deepens native pay equity capabilities beyond core compensation planning.
Help us improve and share your feedback! Did you find this helpful?
Growth & Insights and Company News
6 month growth
1%1 year growth
-1%2 year growth
-1%Sumeru Equity Partners acquired 100% of the share capital of beqom SA, a Swiss-based provider of employee compensation management and performance software solutions for large companies of various industry sectors.
Four startups in the life sciences and ICT sectors have recently restructured their leadership teams, appointing new CEOs, CTOs, and CFOs to propel their growth ambitions. Notably, Cytosurge and beqom have said goodbye to their long-serving leaders, marking the start of a new era in the companies after more than a decade.Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, is advancing a portfolio of transformative, first-in-disease therapeutics targeting neuroscience-based conditions with high unmet needs. Noema has four programs currently in active Phase 2 clinical trials evaluating seizures in Tuberous Sclerosis Complex, pain in Trigeminal Neuralgia, Tourette syndrome and vasomotor symptoms plus CNS-mediated symptoms of menopause with readouts expected in 2025. The company has strengthened its leadership team with the appointment of Michael Samar as Chief Financial Officer (CFO). Michael brings 25 years of experience in life sciences and biotech, serving as both a strategic partner and a financial advisor to growth-phase and impact-driven organizations while helping forge a culture of success. Leadership transition at Cytosurge Cytosurge AG, a biotech company pioneering innovative single-cell biopsies and cell-line engineering solutions, announces a leadership transition effective January 1, 2025
beqom, a leader in compensation management software, is excited to announce that Lars Pedersen has been appointed Chief Executive Officer effective January 8th, 2025.
beqom announced a $300 million strategic investment from Sumeru Equity Partners to fuel product innovation growth to support Compensation and HCM leaders.
beqom announced it will acquire PayAnalytics, a trailblazing pay and workplace equity software provider.